Literature DB >> 32662875

ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020.

Elliott Lilley1, S Clare Stanford2, David E Kendall3, Stephen P H Alexander3, Giuseppe Cirino4, James R Docherty5, Christopher H George6, Paul A Insel7, Angelo A Izzo4, Yong Ji8, Reynold A Panettieri9, Christopher G Sobey10, Barbara Stefanska11, Gary Stephens12, Mauro Teixeira13, Amrita Ahluwalia14.   

Abstract

Mesh：

Year:  2020        PMID： 32662875      PMCID： PMC7393193          DOI： 10.1111/bph.15178

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  13 in total

1.  Animal research: reporting in vivo experiments: the ARRIVE guidelines.

Authors:  Carol Kilkenny; William Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  A mouse's house may ruin experiments.

Authors:  Sara Reardon
Journal:  Nature       Date:  2016-02-18       Impact factor: 49.962

3.  Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP.

Authors:  John C McGrath; Elliot Lilley
Journal:  Br J Pharmacol       Date:  2015-05-12       Impact factor: 8.739

4.  Do as you would be done by: write as you would wish to read.

Authors:  Gordon B Drummond; Sarah L Vowler
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

5.  Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers.

Authors:  Michael J Curtis; Steve Alexander; Giuseppe Cirino; James R Docherty; Christopher H George; Mark A Giembycz; Daniel Hoyer; Paul A Insel; Angelo A Izzo; Yong Ji; David J MacEwan; Christopher G Sobey; S Clare Stanford; Mauro M Teixeira; Sue Wonnacott; Amrita Ahluwalia
Journal:  Br J Pharmacol       Date:  2018-04       Impact factor: 8.739

6.  The effect of standard laboratory diets on estrogen signaling and spatial memory in male and female rats.

Authors:  C A Finney; N W Proschogo; A Snepvangers; N M Holmes; R F Westbrook; K J Clemens
Journal:  Physiol Behav       Date:  2019-12-19

7.  Confusing preclinical (predictive) drug screens with animal 'models' of psychiatric disorders, or 'disorder-like' behaviour, is undermining confidence in behavioural neuroscience.

Authors:  S C Stanford
Journal:  J Psychopharmacol       Date:  2017-01-01       Impact factor: 4.153

Review 8.  Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.

Authors:  Carol Kilkenny; William J Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal:  PLoS Biol       Date:  2010-06-29       Impact factor: 8.029

9.  The Devil Is in the Details: Incomplete Reporting in Preclinical Animal Research.

Authors:  Marc T Avey; David Moher; Katrina J Sullivan; Dean Fergusson; Gilly Griffin; Jeremy M Grimshaw; Brian Hutton; Manoj M Lalu; Malcolm Macleod; John Marshall; Shirley H J Mei; Michael Rudnicki; Duncan J Stewart; Alexis F Turgeon; Lauralyn McIntyre
Journal:  PLoS One       Date:  2016-11-17       Impact factor: 3.240
View more
  93 in total

1.  Antidiabetic activity in vitro and in vivo of BDB, a selective inhibitor of protein tyrosine phosphatase 1B, from Rhodomela confervoides.

Authors:  Jiao Luo; Meiling Zheng; Bo Jiang; Chao Li; Shuju Guo; Lijun Wang; Xiangqian Li; Rilei Yu; Dayong Shi
Journal:  Br J Pharmacol       Date:  2020-08-30       Impact factor: 8.739

2.  Perampanel reduces paroxysmal depolarizing shift and inhibitory synaptic input in excitatory neurons to inhibit epileptic network oscillations.

Authors:  Ya-Chin Yang; Guan-Hsun Wang; Ai-Yu Chuang; Shu-Wei Hsueh
Journal:  Br J Pharmacol       Date:  2020-09-28       Impact factor: 8.739

3.  Streptococcus pneumoniae aminopeptidase N regulates dendritic cells that attenuates type-2 airway inflammation in murine allergic asthma.

Authors:  Guangying Wu; Xuemei Zhang; Xu Chen; Jian Wang; Jing Yang; Ling Wang; Si Sun; Yuhong Qi; Hong Wang; Yibing Yin; Wenchun Xu
Journal:  Br J Pharmacol       Date:  2020-09-20       Impact factor: 8.739

4.  A novel apoA-I mimetic peptide suppresses atherosclerosis by promoting physiological HDL function in apoE-/- mice.

Authors:  Sanhu Gou; Li Wang; Chao Zhong; Xinyue Chen; Xu Ouyang; Beibei Li; Guangjun Bao; Hui Liu; Yun Zhang; Jingman Ni
Journal:  Br J Pharmacol       Date:  2020-09-09       Impact factor: 8.739

5.  Metabolic effects of carvedilol through β-arrestin proteins: investigations in a streptozotocin-induced diabetes rat model and in C2C12 myoblasts.

Authors:  Berna Güven; Zümra Kara; Arzu Onay-Beşikci
Journal:  Br J Pharmacol       Date:  2020-11-15       Impact factor: 8.739

6.  Effects of a monocarboxylate transport 1 inhibitor, AZD3965, on retinal and visual function in the rat.

Authors:  Annette E Allen; Elizabeth A Martin; Katherine Greenwood; Claire Grant; Peter Vince; Robert J Lucas; William S Redfern
Journal:  Br J Pharmacol       Date:  2020-09-13       Impact factor: 8.739

7.  The low-expression programming of 11β-HSD2 mediates osteoporosis susceptibility induced by prenatal caffeine exposure in male offspring rats.

Authors:  Hao Xiao; Zhixin Wu; Bin Li; Yangfan Shangguan; Jean-François Stoltz; Jacques Magdalou; Liaobin Chen; Hui Wang
Journal:  Br J Pharmacol       Date:  2020-08-20       Impact factor: 8.739

8.  Inhibition of γ-glutamyltransferase ameliorates ischaemia-reoxygenation tissue damage in rats with hepatic steatosis.

Authors:  Ryuichi Kubota; Nobuhiko Hayashi; Kaori Kinoshita; Takashi Saito; Kazuaki Ozaki; Yoshimichi Ueda; Mutsumi Tsuchishima; Mikihiro Tsutsumi; Joseph George
Journal:  Br J Pharmacol       Date:  2020-10-19       Impact factor: 8.739

9.  Glycogen synthase kinase-3 inhibition rescues sex-dependent contextual fear memory deficit in human immunodeficiency virus-1 transgenic mice.

Authors:  Shamsudheen Moidunny; Michael A Benneyworth; David J Titus; Eleonore Beurel; Udhghatri Kolli; Joyce Meints; Richa Jalodia; Sundaram Ramakrishnan; Coleen M Atkins; Sabita Roy
Journal:  Br J Pharmacol       Date:  2020-11-23       Impact factor: 8.739

10.  Rho kinase inhibitor fasudil reduces l-DOPA-induced dyskinesia in a rat model of Parkinson's disease.

Authors:  Andrea Lopez-Lopez; Carmen M Labandeira; Jose L Labandeira-Garcia; Ana Muñoz
Journal:  Br J Pharmacol       Date:  2020-11-03       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.